OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to ...

The India Gabapentin Market offers opportunities driven by rising neurological disorders, especially among diabetic and aging ...

A new UK research initiative is set to revolutionise how scientists study human diseases and develop new medicines ...

A major new initiative aims to redefine human-based research models for greater understanding of disease and the acceleration of new medicines.The proposal will enable the development of advanced, ...

Chief Executive Officer — Sandy Macrae Chief Development Officer — Nathalie Dubois-Stringfellow Head of Research and Technology — Gregory Davis Principal Financial Officer and Principal Accounting ...

The global lidocaine market, valued at approximately USD 0.89 billion in 2023, is projected to expand at a compound annual growth rate (CAGR) of 5.26% over the forecast period from 2024 to 2032.

Detailed price information for Rapport Therapeutics Inc (RAPP-Q) from The Globe and Mail including charting and trades.

Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic ...

Multiple people across the globe who stepped forward are speaking about what they say is the debilitating aftermath they now ...

On World Diabetes Awareness Day, Dr Sheila Black, Consultant in Anaesthesia and Pain Medicine at Leeds Teaching Hospitals, is offering hope to thousands of people across Leeds living with Painful ...

Scientists have discovered that the body can naturally dull pain through its own localized “benzodiazepine-like” peptides. A groundbreaking study led by a University of Leeds scientist has unveiled ...

We appreciate the constructive remarks by Chung-Wei Christine Lin and colleagues regarding our systematic review and resulting recommendations.1 Our systematic review and meta-analysis were explicitly ...